Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $830.1900 (-0.03%) ($830.1900 - $830.1900) on Tue. Aug. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.73% (three month average) | RSI | 75 | Latest Price | $830.1900(-0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(63%) IBB(60%) DIA(50%) XLF(50%) SPY(49%) | Factors Impacting REGN price | REGN will decline at least -0.865% in a week (0% probabilities). VXX(-44%) VIXM(-39%) USO(-17%) TBT(-14%) UUP(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.865% (StdDev 1.73%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $832.7(-0.3%) | 10 Day Moving Average | $826.44(0.45%) | 20 Day Moving Average | $805.82(3.02%) | To recent high | -1.7% | To recent low | 19.9% | Market Cap | $88.024b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |